FROM BENCH TO BEDSIDE: HOW TRANSLATIONAL RESEARCH HAS CONTRIBUTED TO THE TREATMENT OF PANCREATIC CANCER

Abstract

This study explores the intersection between translational research and the treatment of pancreatic cancer, a neoplasm with a challenging prognosis. The investigation is justified by the need to convert basic scientific discoveries into effective clinical applications, aiming to improve currently available therapeutic strategies. The main objective is to analyze the contributions of translational research to advances in the management of pancreatic cancer, from molecular understanding to the implementation of new approaches at the patient’s bedside. The methodology adopts a bibliographic approach, of a basic nature and exploratory objective, based on a review of recent scientific literature from specialized databases. The results indicate that translational research drives the development of targeted therapies, immunotherapies, and biomarkers, enabling precision medicine. The conclusions highlight translational research as a fundamental pillar in overcoming therapeutic challenges, promoting treatment personalization and improving patients’ quality of life.